1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Nuclear Medicine Isotopes Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Stable Isotopes
  • 1.2.3 Radioisotopes
• 1.3 Market by Application
  • 1.3.1 Global Nuclear Medicine Isotopes Market Share by Application: 2020 VS 2026
  • 1.3.2 Nuclear Therapy
  • 1.3.3 Equipment Radioactive Source
  • 1.3.4 Diagnosis
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Nuclear Medicine Isotopes Market Perspective (2015-2026)
• 2.2 Global Nuclear Medicine Isotopes Growth Trends by Regions
  • 2.2.1 Nuclear Medicine Isotopes Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Nuclear Medicine Isotopes Historic Market Share by Regions (2015-2020)
  • 2.2.3 Nuclear Medicine Isotopes Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Nuclear Medicine Isotopes Players by Market Size
  • 3.1.1 Global Top Nuclear Medicine Isotopes Players by Revenue (2015-2020)
  • 3.1.2 Global Nuclear Medicine Isotopes Revenue Market Share by Players (2015-2020)
• 3.2 Global Nuclear Medicine Isotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Nuclear Medicine Isotopes Revenue
• 3.4 Global Nuclear Medicine Isotopes Market Concentration Ratio
  • 3.4.1 Global Nuclear Medicine Isotopes Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Isotopes Revenue in 2019
• 3.5 Key Players Nuclear Medicine Isotopes Area Served
• 3.6 Key Players Nuclear Medicine Isotopes Product Solution and Service
• 3.7 Date of Enter into Nuclear Medicine Isotopes Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Nuclear Medicine Isotopes Breakdown Data by Type (2015-2026)

• 4.1 Global Nuclear Medicine Isotopes Historic Market Size by Type (2015-2020)
• 4.2 Global Nuclear Medicine Isotopes Forecasted Market Size by Type (2021-2026)

5 Nuclear Medicine Isotopes Breakdown Data by Application (2015-2026)

• 5.1 Global Nuclear Medicine Isotopes Historic Market Size by Application (2015-2020)
• 5.2 Global Nuclear Medicine Isotopes Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Nuclear Medicine Isotopes Market Size (2015-2026)
• 6.2 North America Nuclear Medicine Isotopes Market Size by Type (2015-2020)
• 6.3 North America Nuclear Medicine Isotopes Market Size by Application (2015-2020)
• 6.4 North America Nuclear Medicine Isotopes Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Nuclear Medicine Isotopes Market Size (2015-2026)
• 7.2 Europe Nuclear Medicine Isotopes Market Size by Type (2015-2020)
• 7.3 Europe Nuclear Medicine Isotopes Market Size by Application (2015-2020)
• 7.4 Europe Nuclear Medicine Isotopes Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Nuclear Medicine Isotopes Market Size (2015-2026)
• 8.2 China Nuclear Medicine Isotopes Market Size by Type (2015-2020)
• 8.3 China Nuclear Medicine Isotopes Market Size by Application (2015-2020)
• 8.4 China Nuclear Medicine Isotopes Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Nuclear Medicine Isotopes Market Size (2015-2026)
• 9.2 Japan Nuclear Medicine Isotopes Market Size by Type (2015-2020)
• 9.3 Japan Nuclear Medicine Isotopes Market Size by Application (2015-2020)
• 9.4 Japan Nuclear Medicine Isotopes Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Nuclear Medicine Isotopes Market Size (2015-2026)
• 10.2 Southeast Asia Nuclear Medicine Isotopes Market Size by Type (2015-2020)
• 10.3 Southeast Asia Nuclear Medicine Isotopes Market Size by Application (2015-2020)
• 10.4 Southeast Asia Nuclear Medicine Isotopes Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 NRG
  • 11.1.1 NRG Company Details
  • 11.1.2 NRG Business Overview
  • 11.1.3 NRG Nuclear Medicine Isotopes Introduction
  • 11.1.4 NRG Revenue in Nuclear Medicine Isotopes Business (2015-2020))
  • 11.1.5 NRG Recent Development
• 11.2 NTP Radioisotopes
  • 11.2.1 NTP Radioisotopes Company Details
  • 11.2.2 NTP Radioisotopes Business Overview
  • 11.2.3 NTP Radioisotopes Nuclear Medicine Isotopes Introduction
  • 11.2.4 NTP Radioisotopes Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 11.2.5 NTP Radioisotopes Recent Development
• 11.3 JSC Isotope
  • 11.3.1 JSC Isotope Company Details
  • 11.3.2 JSC Isotope Business Overview
  • 11.3.3 JSC Isotope Nuclear Medicine Isotopes Introduction
  • 11.3.4 JSC Isotope Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 11.3.5 JSC Isotope Recent Development
• 11.4 ANSTO
  • 11.4.1 ANSTO Company Details
  • 11.4.2 ANSTO Business Overview
  • 11.4.3 ANSTO Nuclear Medicine Isotopes Introduction
  • 11.4.4 ANSTO Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 11.4.5 ANSTO Recent Development
• 11.5 IRE
  • 11.5.1 IRE Company Details
  • 11.5.2 IRE Business Overview
  • 11.5.3 IRE Nuclear Medicine Isotopes Introduction
  • 11.5.4 IRE Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 11.5.5 IRE Recent Development
• 11.6 Nordion
  • 11.6.1 Nordion Company Details
  • 11.6.2 Nordion Business Overview
  • 11.6.3 Nordion Nuclear Medicine Isotopes Introduction
  • 11.6.4 Nordion Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 11.6.5 Nordion Recent Development
• 11.7 Curium Pharma
  • 11.7.1 Curium Pharma Company Details
  • 11.7.2 Curium Pharma Business Overview
  • 11.7.3 Curium Pharma Nuclear Medicine Isotopes Introduction
  • 11.7.4 Curium Pharma Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 11.7.5 Curium Pharma Recent Development
• 11.8 Cambridge Isotope Laboratories
  • 11.8.1 Cambridge Isotope Laboratories Company Details
  • 11.8.2 Cambridge Isotope Laboratories Business Overview
  • 11.8.3 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Introduction
  • 11.8.4 Cambridge Isotope Laboratories Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 11.8.5 Cambridge Isotope Laboratories Recent Development
• 11.9 Eckert & Ziegler Strahlen
  • 11.9.1 Eckert & Ziegler Strahlen Company Details
  • 11.9.2 Eckert & Ziegler Strahlen Business Overview
  • 11.9.3 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Introduction
  • 11.9.4 Eckert & Ziegler Strahlen Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 11.9.5 Eckert & Ziegler Strahlen Recent Development
• 11.10 Polatom
  • 11.10.1 Polatom Company Details
  • 11.10.2 Polatom Business Overview
  • 11.10.3 Polatom Nuclear Medicine Isotopes Introduction
  • 11.10.4 Polatom Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 11.10.5 Polatom Recent Development
• 11.11 Center of Molecular Research
  • 10.11.1 Center of Molecular Research Company Details
  • 10.11.2 Center of Molecular Research Business Overview
  • 10.11.3 Center of Molecular Research Nuclear Medicine Isotopes Introduction
  • 10.11.4 Center of Molecular Research Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 10.11.5 Center of Molecular Research Recent Development
• 11.12 China National Nuclear Corporation
  • 10.12.1 China National Nuclear Corporation Company Details
  • 10.12.2 China National Nuclear Corporation Business Overview
  • 10.12.3 China National Nuclear Corporation Nuclear Medicine Isotopes Introduction
  • 10.12.4 China National Nuclear Corporation Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 10.12.5 China National Nuclear Corporation Recent Development
• 11.13 Urenco
  • 10.13.1 Urenco Company Details
  • 10.13.2 Urenco Business Overview
  • 10.13.3 Urenco Nuclear Medicine Isotopes Introduction
  • 10.13.4 Urenco Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 10.13.5 Urenco Recent Development
• 11.14 LANL
  • 10.14.1 LANL Company Details
  • 10.14.2 LANL Business Overview
  • 10.14.3 LANL Nuclear Medicine Isotopes Introduction
  • 10.14.4 LANL Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 10.14.5 LANL Recent Development
• 11.15 Shanghai Engineering Research Center
  • 10.15.1 Shanghai Engineering Research Center Company Details
  • 10.15.2 Shanghai Engineering Research Center Business Overview
  • 10.15.3 Shanghai Engineering Research Center Nuclear Medicine Isotopes Introduction
  • 10.15.4 Shanghai Engineering Research Center Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 10.15.5 Shanghai Engineering Research Center Recent Development
• 11.16 IDB Holland
  • 10.16.1 IDB Holland Company Details
  • 10.16.2 IDB Holland Business Overview
  • 10.16.3 IDB Holland Nuclear Medicine Isotopes Introduction
  • 10.16.4 IDB Holland Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 10.16.5 IDB Holland Recent Development
• 11.17 NHTC
  • 10.17.1 NHTC Company Details
  • 10.17.2 NHTC Business Overview
  • 10.17.3 NHTC Nuclear Medicine Isotopes Introduction
  • 10.17.4 NHTC Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 10.17.5 NHTC Recent Development
• 11.18 Linde
  • 10.18.1 Linde Company Details
  • 10.18.2 Linde Business Overview
  • 10.18.3 Linde Nuclear Medicine Isotopes Introduction
  • 10.18.4 Linde Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 10.18.5 Linde Recent Development
• 11.19 ORNL
  • 10.19.1 ORNL Company Details
  • 10.19.2 ORNL Business Overview
  • 10.19.3 ORNL Nuclear Medicine Isotopes Introduction
  • 10.19.4 ORNL Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 10.19.5 ORNL Recent Development
• 11.20 SI Science
  • 10.20.1 SI Science Company Details
  • 10.20.2 SI Science Business Overview
  • 10.20.3 SI Science Nuclear Medicine Isotopes Introduction
  • 10.20.4 SI Science Revenue in Nuclear Medicine Isotopes Business (2015-2020)
  • 10.20.5 SI Science Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Nuclear Medicine Isotopes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine Isotopes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Stable Isotopes
Radioisotopes

Market segment by Application, split into
Nuclear Therapy
Equipment Radioactive Source
Diagnosis

Based on regional and country-level analysis, the Nuclear Medicine Isotopes market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Nuclear Medicine Isotopes market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL